This company has been marked as potentially delisted and may not be actively trading. 4D pharma (LBPS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock LBPS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Human Microbiome Market with Business Strategy, Key Drivers, Opportunities, Top Key Companies Analysis and ForecastNovember 9, 2024 | theglobeandmail.comLive Biotherapeutic Products and Microbiome Contract Manufacturing Market Experiences Significant GrowthSeptember 8, 2024 | theglobeandmail.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Doximity (DOCS), 4D Molecular Therapeutics (FDMT) and Cullinan Management (CGEM)August 13, 2024 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: 4D Molecular Therapeutics (FDMT), Intuitive Surgical (ISRG)July 23, 2024 | markets.businessinsider.com4D Molecular Therapeutics: Yesterday's Wet-AMD Data Given Thumbs Down By MarketJuly 20, 2024 | seekingalpha.com4D Molecular Therapeutics new overweight at Barclays on genetic medicine platformApril 15, 2024 | msn.comLancashire: pharmacy robots speed up prescription pickingApril 8, 2024 | msn.comPROGRESS 2024: In business for more than 60 years, Professional Pharmacy offers a wide range of servicesMarch 30, 2024 | yahoo.comNAT-STORY4D-Pharmacy first scheme could free up 30 million GP appointments annuallyMarch 18, 2024 | msn.comStrong Buy Recommendation for 4D Molecular Therapeutics Amid Promising 4D-150 Gene Therapy Study ResultsFebruary 13, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), BridgeBio Pharma (BBIO) and Phibro Animal Health (PAHC)February 8, 2024 | markets.businessinsider.comBuy Rating for 4D Molecular Therapeutics Backed by Promising 4D-150 Gene Therapy Trial ResultsFebruary 5, 2024 | markets.businessinsider.com4D Molecular Therapeutics Shares Rise 33% After Positive Trial DataFebruary 5, 2024 | marketwatch.com4D Molecular Therapeutics GAAP EPS of -$0.24 beats by $0.37, revenue of $20.2M beats by $10.98MNovember 9, 2023 | msn.com4D Molecular Therapeutics GAAP EPS of -$0.77 misses by $0.01, revenue of $0.24M misses by $0.78MAugust 9, 2023 | msn.comHuman Microbiome Market worth $1.7 billion by 2029July 14, 2023 | benzinga.comThe 4D Bioprinting Market is anticipated to grow at a CAGR of around 35% by 2035, claims Roots AnalysisMay 6, 2023 | benzinga.com4D Molecular Therapeutics proposes $100M stock offeringMay 4, 2023 | msn.com4D Molecular Therapeutics, Inc. (FDMT) Reports Q4 Loss, Lags Revenue EstimatesMarch 15, 2023 | msn.comHuman Microbiome Market Report 2023-2033February 7, 2023 | finance.yahoo.comHow Is The Market Feeling About 4D Molecular Therapeutics?December 15, 2022 | msn.comExpert Ratings for 4D Molecular TherapeuticsNovember 18, 2022 | markets.businessinsider.comMicrobiome Therapeutics Market to Boom at Robust CAGR to Cross USD 746 Million by 2028 | BlueWeave ConsultingOctober 4, 2022 | benzinga.comX4 Pharmaceuticals: Upcoming CatalystsSeptember 20, 2022 | seekingalpha.com4D pharma stock to be delisted from Nasdaq after co was placed into administrationJune 28, 2022 | seekingalpha.com4D pharma plc ("4D pharma") Receives Notice of Delisting From NasdaqJune 28, 2022 | finance.yahoo.comTrading was temporarily halted for "LBPS" at 09:06 AM with a stated reason of "News pending."June 24, 2022 | marketbeat.com4D pharma Presents Trial in Progress Poster on Study of MRx0518 in Combination with BAVENCIO® in Patients with Unresectable Locally Advanced or Metastatic Urothelial Carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingMay 26, 2022 | finance.yahoo.com4D pharma to Present at the H.C. Wainwright Global Investment ConferenceMay 19, 2022 | finance.yahoo.com4D pharma Shares Rise on Encouraging Results From Asthma Treatment TrialMay 17, 2022 | marketwatch.com4D Pharma Presents Data Supporting Potential Of MRx-4DP0004 As Oral Treatment For AsthmaMay 17, 2022 | nasdaq.com4D Pharma has a busy year ahead after a successful 12 months of clinical researchApril 1, 2022 | proactiveinvestors.com4D pharma reports FY resultsMarch 31, 2022 | seekingalpha.com4D pharma Reports Full Year 2021 Financial Results, Operational Highlights, and Guidance for Key Milestones in 2022March 31, 2022 | finance.yahoo.com4D pharma stock soars 56% as drug combo meets efficacy goal early in kidney cancer groupMarch 23, 2022 | seekingalpha.comTrading was temporarily halted for "LBPS" at 09:03 AM with a stated reason of "LULD pause."March 23, 2022 | marketbeat.comTrading was temporarily halted for "LBPS" at 09:03 AM with a stated reason of "LULD pause."March 23, 2022 | marketbeat.comACHR,EBON and GENI among pre market gainersMarch 12, 2022 | seekingalpha.com4D pharma gets green light for phase I clinical trial of Parkinson's disease candidatesFebruary 23, 2022 | proactiveinvestors.com4D Pharma To Test Its Single-Strain Live Biotherapeutics In Parkinson's DiseaseFebruary 22, 2022 | msn.comTrading was temporarily halted for "LBPS" at 09:02 AM with a stated reason of "LULD pause."February 22, 2022 | marketbeat.com4D Pharma Shares Rise as Parkinson's Trial Receives FDA ClearanceFebruary 22, 2022 | morningstar.com4D pharma Announces FDA Clearance of IND Application for Live Biotherapeutics MRx0005 and MRx0029 for the Treatment of Parkinson’s DiseaseFebruary 22, 2022 | finance.yahoo.com4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of EfficacyJanuary 28, 2022 | benzinga.com4D Pharma reports additional positive data from Part A of mid-stage asthma drug trialJanuary 27, 2022 | seekingalpha.com4D pharma Announces Additional Positive Data From Part A of the Phase I/II Trial Of MRx-4DP0004 For the Treatment of AsthmaJanuary 27, 2022 | finance.yahoo.com4D pharma hails 'highly encouraging' data from its early-stage asthma trialJanuary 27, 2022 | proactiveinvestors.com4D pharma to Host Virtual KOL Event Discussing Asthma Treatment Landscape and Review of Positive Topline Results from Part A of Phase I/II Trial of MRx-4DP0004January 20, 2022 | finance.yahoo.com4d Pharma Plc - ADR Shares Near 52-Week Low - Market MoverJanuary 8, 2022 | nasdaq.com4D pharma plc: 4D pharma to Present at the H.C. Wainwright BioConnect ConferenceJanuary 5, 2022 | finanznachrichten.de Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPS and its competitors with MarketBeat's FREE daily newsletter. Email Address LBPS Media Mentions By Week LBPS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBPS News Sentiment▼0.000.87▲Average Medical News Sentiment LBPS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBPS Articles This Week▼00▲LBPS Articles Average Week Get 4D pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NTHI News SEEL News LLY News JNJ News ABBV News NVO News NVS News ABT News AZN News MRK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LBPS) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LBPS Stock Free LBPS Stock Alerts